AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kezar Life Sciences, Inc. Director's Dealing 2024

Jun 21, 2024

34845_dirs_2024-06-21_6e4cb5e3-79f5-487f-acc4-05402a4feed5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2024-06-20

Reporting Person: BERGER FRANKLIN M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-20	Stock Option (right to buy)	$0.67	A	50000	Acquired	2034-06-19	Common Stock (50000)	Direct

Footnotes

F1: One-hundred percent (100%) of the shares subject to the option shall vest on 6/20/2025, subject to Reporting Person continuing to provide service through such date.